SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome

Eddiry, S., Diene, G., Molinas, C., Salles, J., Auriol, F. C., Gennero, I., Bieth, E., Skryabin, B. V., Rozhdestvensky, T. S., Burnett, L. C., Leibel, R. L., Tauber, M., & Salles, J. P. (2021). SNORD116 and growth hormone therapy impact IGFBP7 in Prader–Willi syndrome. Genetics in Medicine, 23(9), 1664–1672. https://doi.org/10.1038/s41436-021-01185-y
Authors:
Sanaa Eddiry
Gwenaelle Diene
Catherine Molinas
Juliette Salles
Françoise Conte Auriol
Isabelle Gennero
Eric Bieth
Boris V. Skryabin
Timofey S. Rozhdestvensky
Lisa C. Burnett
Rudolph L. Leibel
Maithé Tauber
Jean Pierre Salles
Affiliated Authors:
Rudolph L. Leibel
Publication Type:
Article
Unique ID:
10.1038/s41436-021-01185-y
PMID:
Publication Date:
Data Source:
Scopus

Record Created: